Skip to content

FREMED

Active
Private limited companyfounded 1978active for 47 yearsLangemeersstraat(Kor) 12/C, 8500 Kortrijk, Belgium14 active companies are registered at this addressKBO/BCE: BE 0419.037.822
Summary

The computed 12-month bankruptcy probability of FREMED is 2.6% (moderate). The 2025 annual accounts show negative equity (-€22,959) and a net result of -€4,495. Equity is shrinking by about 12% per year across the filed financial years. Its solvency ranks better than 9% of 13,626 sector peers (NACE 46, financial year 2025). The company has been active since 1978 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€21,724total assets 2025
Equity
-€22,959
Loss
-€4,495
Turnover not published (micro format)
Financial health
49 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.6%
Structure
Accounts 127 days early2 of 4 deeds read
Why 49raises riskLoss of €4,495, the second in a row (financial year 2025)1 change of registered office in 24 monthsNegative equity -€22,959lowers riskSize: total assets €21,724Show the evidence

Checked score

Score 2025
49 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 11% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Weak
Solvency 0=
equity -105.7% of total assets
Liquidity 16-24
short-term debt 205.7% · cash 12.8%
Profitability 0-37
return on assets -20.7%
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,868 companies, NACE 46, micro)
Last 24 months 11-2024: 1.7% 12-2024: 2.9%▲ +1.2 percentage points vs 11-2024 01-2025: 5.6%▲ +2.7 percentage points vs 12-2024 02-2025: 5.6%● unchanged vs 01-2025 03-2025: 5.9%▲ +0.3 percentage points vs 02-2025 04-2025: 5.4%▼ -0.5 percentage points vs 03-2025 05-2025: 5.4%● unchanged vs 04-2025 06-2025: 5.4%● unchanged vs 05-2025 07-2025: 5.4%● unchanged vs 06-2025 08-2025: 7.5%▲ +2.1 percentage points vs 07-2025 09-2025: 7.5%● unchanged vs 08-2025 10-2025: 7.5%● unchanged vs 09-2025 11-2025: 8.3%▲ +0.8 percentage points vs 10-2025highest value 12-2025: 8.3%● unchanged vs 11-2025highest value 01-2026: 8.3%● unchanged vs 12-2025highest value 02-2026: 8.3%● unchanged vs 01-2026highest value 03-2026: 8.3%● unchanged vs 02-2026highest value 04-2026: 1.4%▼ -6.9 percentage points vs 03-2026 05-2026: 1.4%● unchanged vs 04-2026lowest value 06-2026: 1.4%● unchanged vs 05-2026lowest value 07-2026: 2.6%▲ +1.2 percentage points vs 06-2026 08-2026: 2.6%● unchanged vs 07-2026 09-2026: 2.6%● unchanged vs 08-2026 10-2026: 2.6%● unchanged vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.4, compared with 0.55 in 2024, below 1; short-term debt: 205.7% and cash: 12.8% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 6% on solvency, 16% on liquidity, 6% on profitability and 17% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €21,724
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Loss of €4,495, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Negative equity -€22,959
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€22,959
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-03-2026, 127 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
127 days early
2024
237 days late
2023
600 days late
2022
60 days late
2021
9 days early
2020
8 days early
2019
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 104 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 September (4 of the last 5 filed years within 187 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Registered officeRegistered-office move · Power of…
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Risk: Negative equityfinancial year 2025: debts exceed assets -€22,959 View
  • Risk: 3 loss-making years in a rowloss financial year 2025 -€4,495 View
  • Caution: Among the weakest 9% on solvencysector median 40.7% · 13,626 companies -105.7% View
  • Active since 1978founded 29-12-1978 47 years View

By topic

Financials

Financial year
2025
Total assets
€21,724
Loss
-€4,495
Solvency
-105.7%
Total assets▼ 2.7%
Net result
20182025
Go to Financials

Timeline

Events
51
Since
1980
Next accounts
by 31-07-2027
  1. 23-03-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 26-06-2024Resignation: DOBBELAERE Christiana Thérèse Marie (sole director)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
29-12-1978
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.